Fortress Biotech Ownership 2024 | Who Owns Fortress Biotech Now?


OverviewRevenueFinancialsChart

Institutional Ownership

18.02%

Insider Ownership

22.55%

Retail Ownership

59.43%

Institutional Holders

46.00

Fortress Biotech Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
B. RILEY WEALTH ADVISORS, INC.0.96%0.00%144,700144,700100.00%42,006Mar 31, 2024

Fortress Biotech's largest institutional shareholder is B. RILEY WEALTH ADVISORS, INC., holding 0.96% of the company's total share outstanding, currently valued at $42.01K. The top 10 institutional shareholders own together 0.96% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
B. RILEY WEALTH ADVISORS, INC.0.96%0.00%144,700144,700100.00%42,006Mar 31, 2024

The largest Fortress Biotech shareholder by % of total assets is B. RILEY WEALTH ADVISORS, INC.. The company owns 144.70K shares of Fortress Biotech (FBIO), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
B. RILEY WEALTH ADVISORS, INC.0.96%0.00%144,700144,700100.00%42,006Mar 31, 2024

As of Mar 31 2024, Fortress Biotech's largest institutional buyer is B. RILEY WEALTH ADVISORS, INC.. The company purchased 144.70K stocks of FBIO, valued at $42.01K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
B. RILEY WEALTH ADVISORS, INC.0.96%0.00%144,700144,700100.00%42,006Mar 31, 2024

As of Mar 31 2024, Fortress Biotech's biggest institutional seller is B. RILEY WEALTH ADVISORS, INC.. The company sold 144.70K shares of FBIO, valued at $42.01K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Fortress Biotech Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.27%130,700--Dec 31, 2023
VANGUARD EXPLORER FUND0.14%1,732,308--Jan 31, 2024
World Funds Trust0.12%69,500--Jan 31, 2024
DELAWARE GROUP EQUITY FUNDS IV0.09%100,000--Dec 29, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%10,826--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.02%112,543--Dec 31, 2023
SSGA FUNDS0.01%3,657--Feb 29, 2024
World Funds Trust0.01%4,633--Jan 31, 2024
Fidelity Commonwealth Trust II0.01%54,189--Aug 31, 2023
TIAA SEPARATE ACCOUNT VA 10.01%1,841--Dec 31, 2023
ALPS ETF Trust0.01%96,454--Feb 29, 2024
VANGUARD INDEX FUNDS0.01%3,286,551--Dec 31, 2023
DELAWARE GROUP EQUITY FUNDS IV0.01%6,6666,666-Dec 29, 2023
FIDELITY CONCORD STREET TRUST0.00%809,169--Feb 29, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%151,271--Dec 31, 2023
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%11,060--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%29,605--Dec 31, 2023
Calvert Variable Products, Inc.0.00%5,129--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%57,880--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%20,62920,629-Dec 31, 2023
ADVISORS' INNER CIRCLE FUND0.00%16,935--Jan 31, 2024
SunAmerica Specialty Series0.00%518--Apr 30, 2021
GPS Funds I0.00%4,893--Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%4,058--Dec 31, 2023
Voya VARIABLE PORTFOLIOS INC0.00%26,240--Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%2,167--Dec 31, 2023
VANGUARD INDEX FUNDS0.00%349,278349,278-Dec 31, 2023
SCHWAB CAPITAL TRUST0.00%29,965--Feb 29, 2024
Virtus Strategy Trust0.00%16,242--Dec 29, 2023
AdvisorShares Trust0.00%2,136--Dec 29, 2023
Meeder Funds0.00%2,533--Mar 31, 2024
RBB FUND, INC.0.00%44,900--Feb 29, 2024
ALLSPRING MASTER TRUST0.00%25,560--Feb 29, 2024
FIDELITY SALEM STREET TRUST0.00%551,143--Feb 29, 2024
RUSSELL INVESTMENT FUNDS0.00%14,968--Dec 31, 2023
ProFunds0.00%1,564--Jan 31, 2024
RYDEX SERIES FUNDS0.00%702--Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%14,000--Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%2,739--Feb 29, 2024
PGIM ETF TRUST0.00%8,345--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%242,299--Feb 29, 2024
LAZARD FUNDS INC0.00%3,447--Dec 31, 2023
RYDEX DYNAMIC FUNDS0.00%401--Dec 31, 2023
VALIC Co I0.00%27,197--Feb 29, 2024
PENN SERIES FUNDS INC0.00%2,400--Dec 29, 2023
Guggenheim Active Allocation Fund0.00%432--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%9,554--Dec 31, 2023
FLEXSHARES TRUST0.00%5,076--Jan 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%8,195--Jan 31, 2024
RYDEX VARIABLE TRUST0.00%71--Dec 31, 2023
Goldman Sachs ETF Trust0.00%4,627--Feb 29, 2024
NORTHERN FUNDS0.00%40,085--Dec 29, 2023
PACE SELECT ADVISORS TRUST0.00%13,612--Jan 31, 2024
PROSHARES TRUST0.00%10,574--Feb 29, 2024
Advisors' Inner Circle Fund II0.00%28,573--Jan 31, 2024
VANGUARD WELLINGTON FUND0.00%13,107--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%3,102--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%61,000--Dec 31, 2023
SUNAMERICA SERIES TRUST0.00%8,091--Jan 31, 2024
Brighthouse Funds Trust II0.00%30,568--Dec 31, 2023
EQ ADVISORS TRUST0.00%13,500--Dec 31, 2023
VANGUARD QUANTITATIVE FUNDS0.00%100--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%12,816--Dec 31, 2023
SEI INSTITUTIONAL MANAGED TRUST0.00%27,855--Dec 31, 2023
PACIFIC SELECT FUND0.00%24,282--Dec 31, 2023
Advisors' Inner Circle Fund III0.00%103--Jan 31, 2024
iSHARES TRUST0.00%100,939--Feb 29, 2024
MASSMUTUAL SELECT FUNDS0.00%6,011--Dec 31, 2023
Goldman Sachs Trust II0.00%33,600--Jan 31, 2024
PRINCIPAL FUNDS, INC.0.00%11,861--Feb 29, 2024
BlackRock Variable Series Funds, Inc.0.00%7,258--Dec 31, 2023
BLACKROCK FUNDS0.00%11,540--Feb 29, 2024
Bridge Builder Trust0.00%8,304--Dec 31, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%1,857--Dec 31, 2023
John Hancock Funds II0.00%9,268--Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%13,200--Feb 29, 2024

Fortress Biotech's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 130.70K shares, compromising 0.27% of its total assets.

Fortress Biotech Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Sep, 2346-
30 Jun, 2346-16.36%
31 Mar, 235514.58%
31 Dec, 2248-14.29%
30 Sep, 2256-6.67%
30 Jun, 2260-22.08%
31 Mar, 2277-6.10%
31 Dec, 2182-
30 Sep, 2182-3.53%
30 Jun, 21852.41%
31 Mar, 2183-3.49%
31 Dec, 208613.16%
30 Sep, 20764.11%
30 Jun, 207335.19%
31 Mar, 20541.89%
31 Dec, 19538.16%
30 Sep, 19496.52%
30 Jun, 1946-2.13%
31 Mar, 1947-14.55%
31 Dec, 1855-15.38%
30 Sep, 18654.84%
30 Jun, 1862-3.13%
31 Mar, 186410.34%
31 Dec, 17581.75%
30 Sep, 175711.76%
30 Jun, 175110.87%
31 Mar, 1746-9.80%
31 Dec, 1651-3.77%
30 Sep, 1653-5.36%
30 Jun, 165633.33%
31 Mar, 16425.00%
31 Dec, 15402.56%
30 Sep, 1539-4.88%
30 Jun, 15411950.00%
31 Mar, 152-

As of 30 Sep 23, 46 institutions are holding Fortress Biotech's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Sep, 2319,944,606-17.30%
30 Jun, 2324,116,793-15.69%
31 Mar, 2328,604,2074.06%
31 Dec, 2227,489,482-8.48%
30 Sep, 2230,036,713-2.22%
30 Jun, 2230,719,228-13.44%
31 Mar, 2235,488,37210.24%
31 Dec, 2132,192,6596.46%
30 Sep, 2130,238,2100.94%
30 Jun, 2129,956,737-4.21%
31 Mar, 2131,272,237-2.08%
31 Dec, 2031,935,8653.65%
30 Sep, 2030,812,66636.36%
30 Jun, 2022,595,826155.40%
31 Mar, 208,847,18530.41%
31 Dec, 196,783,9952.79%
30 Sep, 196,599,7866.89%
30 Jun, 196,174,408-5.93%
31 Mar, 196,563,829-8.08%
31 Dec, 187,141,085-15.38%
30 Sep, 188,438,85811.06%
30 Jun, 187,598,13512.60%
31 Mar, 186,747,97512.04%
31 Dec, 176,022,908-1.31%
30 Sep, 176,102,6981.13%
30 Jun, 176,034,303-6.50%
31 Mar, 176,454,094-3.08%
31 Dec, 166,659,279-6.81%
30 Sep, 167,145,680-12.01%
30 Jun, 168,120,56129.44%
31 Mar, 166,273,395-0.97%
31 Dec, 156,335,106-44.63%
30 Sep, 1511,442,30635.64%
30 Jun, 158,435,67712349.16%
31 Mar, 1567,761-

Fortress Biotech (FBIO) has 19.94M shares outstanding as of 30 Sep 23, down -17.30% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Sep, 2318.02%3.22%
30 Jun, 2323.67%3.00%
31 Mar, 2328.07%2.93%
31 Dec, 2230.93%2.74%
30 Sep, 2233.59%2.80%
30 Jun, 2234.62%2.04%
31 Mar, 2241.14%2.65%
31 Dec, 2139.40%2.85%
30 Sep, 2137.17%2.72%
30 Jun, 2137.00%2.47%
31 Mar, 2138.68%1.97%
31 Dec, 2044.35%2.70%
30 Sep, 2040.49%3.73%
30 Jun, 2032.96%16.98%
31 Mar, 2013.93%9.06%
31 Dec, 1912.40%9.20%
30 Sep, 1911.61%8.79%
30 Jun, 1911.49%6.28%
31 Mar, 1913.53%6.24%
31 Dec, 1814.72%4.15%
30 Sep, 1818.83%6.14%
30 Jun, 1817.52%6.95%
31 Mar, 1815.87%7.91%
31 Dec, 1714.17%6.31%
30 Sep, 1714.99%6.77%
30 Jun, 1714.88%5.82%
31 Mar, 1715.99%5.87%
31 Dec, 1616.50%5.20%
30 Sep, 1617.81%4.29%
30 Jun, 1620.37%8.14%
31 Mar, 1615.82%8.76%
31 Dec, 1513.44%1.59%
30 Sep, 1529.03%6.24%
30 Jun, 1521.56%69867.73%
31 Mar, 150.18%-

As of 30 Sep 23, Fortress Biotech is held by 18.02% institutional shareholders, representing a 3.22% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Sep, 231633.33%
30 Jun, 2312-53.85%
31 Mar, 232673.33%
31 Dec, 2215-28.57%
30 Sep, 2221-25.00%
30 Jun, 2228-9.68%
31 Mar, 2231-20.51%
31 Dec, 213911.43%
30 Sep, 2135-2.78%
30 Jun, 21369.09%
31 Mar, 2133-31.25%
31 Dec, 204811.63%
30 Sep, 2043-14.00%
30 Jun, 205072.41%
31 Mar, 202916.00%
31 Dec, 1925-
30 Sep, 192519.05%
30 Jun, 192116.67%
31 Mar, 1918-14.29%
31 Dec, 1821-32.26%
30 Sep, 1831-11.43%
30 Jun, 183525.00%
31 Mar, 18287.69%
31 Dec, 1726-18.75%
30 Sep, 173245.45%
30 Jun, 1722-
31 Mar, 17224.76%
31 Dec, 162110.53%
30 Sep, 1619-44.12%
30 Jun, 1634142.86%
31 Mar, 1614-17.65%
31 Dec, 151721.43%
30 Sep, 1514-65.00%
30 Jun, 15401900.00%
31 Mar, 152-

16 institutional shareholders have increased their position in FBIO stock as of 30 Sep 23 compared to 12 in the previous quarter (a 33.33% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Sep, 2312-20.00%
30 Jun, 231566.67%
31 Mar, 239-35.71%
31 Dec, 2214-12.50%
30 Sep, 2216-23.81%
30 Jun, 2221-22.22%
31 Mar, 22278.00%
31 Dec, 21258.70%
30 Sep, 2123-20.69%
30 Jun, 21293.57%
31 Mar, 212827.27%
31 Dec, 202257.14%
30 Sep, 2014180.00%
30 Jun, 205-44.44%
31 Mar, 209-18.18%
31 Dec, 1911-15.38%
30 Sep, 191318.18%
30 Jun, 1911-21.43%
31 Mar, 1914-12.50%
31 Dec, 181633.33%
30 Sep, 1812-7.69%
30 Jun, 1813-23.53%
31 Mar, 181721.43%
31 Dec, 171427.27%
30 Sep, 1711-21.43%
30 Jun, 17147.69%
31 Mar, 17138.33%
31 Dec, 1612-20.00%
30 Sep, 161550.00%
30 Jun, 1610-16.67%
31 Mar, 1612-20.00%
31 Dec, 1515-
30 Sep, 15151400.00%
30 Jun, 151-
31 Mar, 15--

12 institutional shareholders have reduced their position in FBIO stock as of 30 Sep 23 compared to 15 in the previous quarter (a -20.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Sep, 2346-19,944,606-17.30%18.02%3.22%1633.33%12-20.00%
30 Jun, 2346-16.36%24,116,793-15.69%23.67%3.00%12-53.85%1566.67%
31 Mar, 235514.58%28,604,2074.06%28.07%2.93%2673.33%9-35.71%
31 Dec, 2248-14.29%27,489,482-8.48%30.93%2.74%15-28.57%14-12.50%
30 Sep, 2256-6.67%30,036,713-2.22%33.59%2.80%21-25.00%16-23.81%
30 Jun, 2260-22.08%30,719,228-13.44%34.62%2.04%28-9.68%21-22.22%
31 Mar, 2277-6.10%35,488,37210.24%41.14%2.65%31-20.51%278.00%
31 Dec, 2182-32,192,6596.46%39.40%2.85%3911.43%258.70%
30 Sep, 2182-3.53%30,238,2100.94%37.17%2.72%35-2.78%23-20.69%
30 Jun, 21852.41%29,956,737-4.21%37.00%2.47%369.09%293.57%
31 Mar, 2183-3.49%31,272,237-2.08%38.68%1.97%33-31.25%2827.27%
31 Dec, 208613.16%31,935,8653.65%44.35%2.70%4811.63%2257.14%
30 Sep, 20764.11%30,812,66636.36%40.49%3.73%43-14.00%14180.00%
30 Jun, 207335.19%22,595,826155.40%32.96%16.98%5072.41%5-44.44%
31 Mar, 20541.89%8,847,18530.41%13.93%9.06%2916.00%9-18.18%
31 Dec, 19538.16%6,783,9952.79%12.40%9.20%25-11-15.38%
30 Sep, 19496.52%6,599,7866.89%11.61%8.79%2519.05%1318.18%
30 Jun, 1946-2.13%6,174,408-5.93%11.49%6.28%2116.67%11-21.43%
31 Mar, 1947-14.55%6,563,829-8.08%13.53%6.24%18-14.29%14-12.50%
31 Dec, 1855-15.38%7,141,085-15.38%14.72%4.15%21-32.26%1633.33%
30 Sep, 18654.84%8,438,85811.06%18.83%6.14%31-11.43%12-7.69%
30 Jun, 1862-3.13%7,598,13512.60%17.52%6.95%3525.00%13-23.53%
31 Mar, 186410.34%6,747,97512.04%15.87%7.91%287.69%1721.43%
31 Dec, 17581.75%6,022,908-1.31%14.17%6.31%26-18.75%1427.27%
30 Sep, 175711.76%6,102,6981.13%14.99%6.77%3245.45%11-21.43%
30 Jun, 175110.87%6,034,303-6.50%14.88%5.82%22-147.69%
31 Mar, 1746-9.80%6,454,094-3.08%15.99%5.87%224.76%138.33%
31 Dec, 1651-3.77%6,659,279-6.81%16.50%5.20%2110.53%12-20.00%
30 Sep, 1653-5.36%7,145,680-12.01%17.81%4.29%19-44.12%1550.00%
30 Jun, 165633.33%8,120,56129.44%20.37%8.14%34142.86%10-16.67%
31 Mar, 16425.00%6,273,395-0.97%15.82%8.76%14-17.65%12-20.00%
31 Dec, 15402.56%6,335,106-44.63%13.44%1.59%1721.43%15-
30 Sep, 1539-4.88%11,442,30635.64%29.03%6.24%14-65.00%151400.00%
30 Jun, 15411950.00%8,435,67712349.16%21.56%69867.73%401900.00%1-
31 Mar, 152-67,761-0.18%-2---

Fortress Biotech Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 09, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy50,000$2.38$118.77K2,863,905
Nov 16, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy1,567,515$1.70$2.66M2,597,440
Nov 16, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy1,567,515$1.70$2.66M1,567,515
Nov 16, 2023WEISS MICHAEL Sdirector, officer See RemarksP-PurchaseBuy147,058$1.70$250.00K1,130,520
Nov 16, 2023WEISS MICHAEL Sdirector, officer See RemarksP-PurchaseBuy147,058$1.70$250.00K147,058
Sep 27, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy100,000$0.28$28.33K15,449,091
Aug 21, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy10,000$9.34$93.40K112,500
Aug 21, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy10,000$11.75$117.50K102,500
Feb 14, 2023WEISS MICHAEL Sdirector, 10 percent owner, officer See RemarksP-PurchaseBuy1,197,604$0.83$1000.00K14,752,034

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 09, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy50,000$2.38$118.77K2,863,905
Nov 16, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy1,567,515$1.70$2.66M2,597,440
Nov 16, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy1,567,515$1.70$2.66M1,567,515
Nov 16, 2023WEISS MICHAEL Sdirector, officer See RemarksP-PurchaseBuy147,058$1.70$250.00K1,130,520
Nov 16, 2023WEISS MICHAEL Sdirector, officer See RemarksP-PurchaseBuy147,058$1.70$250.00K147,058
Sep 27, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy100,000$0.28$28.33K15,449,091
Aug 21, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy10,000$9.34$93.40K112,500
Aug 21, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy10,000$11.75$117.50K102,500
Feb 14, 2023WEISS MICHAEL Sdirector, 10 percent owner, officer See RemarksP-PurchaseBuy1,197,604$0.83$1000.00K14,752,034

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 02, 2024Jin Davidofficer Chief Financial OfficerA-AwardBuy2,352$1.70$4.00K238,268
Jan 09, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy50,000$2.38$118.77K2,863,905
Jan 03, 2024Lu Lucydirector-A-AwardBuy3,333--11,890
Jan 03, 2024Lorenz Kevindirector-A-AwardBuy3,333--24,304
Jan 03, 2024LOBELL J JAYdirector-A-AwardBuy6,666--115,692
Jan 03, 2024Klein Dovdirector-A-AwardBuy6,666--63,400
Jan 03, 2024Hoenlein Malcolmdirector-A-AwardBuy3,333--39,042
Jan 03, 2024Harvey Jimmiedirector-A-AwardBuy6,666--69,999
Jan 03, 2024WEISS MICHAEL Sdirector, 10 percent owner, officer See RemarksA-AwardBuy216,465--1,346,985
Jan 03, 2024Rowinsky Eric Kdirector-A-AwardBuy6,666--68,797
Jan 03, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanA-AwardBuy216,465--2,813,905
Dec 22, 2023Jin Davidofficer Chief Financial OfficerA-AwardBuy140,000--235,916
Nov 16, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy1,567,515$1.70$2.66M2,597,440
Nov 16, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy1,567,515$1.70$2.66M1,567,515
Nov 16, 2023WEISS MICHAEL Sdirector, officer See RemarksP-PurchaseBuy147,058$1.70$250.00K1,130,520
Nov 16, 2023WEISS MICHAEL Sdirector, officer See RemarksP-PurchaseBuy147,058$1.70$250.00K147,058
Sep 27, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy100,000$0.28$28.33K15,449,091
Aug 21, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy10,000$9.34$93.40K112,500
Aug 21, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy10,000$11.75$117.50K102,500
Feb 14, 2023WEISS MICHAEL Sdirector, 10 percent owner, officer See RemarksP-PurchaseBuy1,197,604$0.83$1000.00K14,752,034

The last insider buy of FBIO was made by ROSENWALD LINDSAY A MD on Jan 09 2024, buying 50,000 shares at $2.38 per share (worth $118.77K).

Fortress Biotech Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20241--
Q1 202410--
Q4 20235--
Q3 20233--
Q2 20232--
Q1 202315--
Q4 202261600.00%
Q3 2022-1-
Q2 20221--
Q1 20228--
Q4 202141400.00%
Q3 202141400.00%
Q2 20211--
Q1 202185160.00%
Q4 20201--
Q3 202021200.00%
Q2 20201--
Q1 20208--
Q4 20191--
Q3 20191250.00%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Fortress Biotech's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 20241--
Q4 20234--
Q3 20233--
Q2 2023---
Q1 20236--
Q4 20224--
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021-1-
Q3 2021-1-
Q2 2021---
Q1 20211520.00%
Q4 2020---
Q3 202021200.00%
Q2 2020---
Q1 20201--
Q4 20191--
Q3 2019---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Fortress Biotech's stocks.

Fortress Biotech Peer Ownership


TickerCompany
EYENEyenovia, Inc.
CKPTCheckpoint Therapeutics, Inc.
ALRNAileron Therapeutics, Inc.
RNAZTransCode Therapeutics, Inc.
MBIOMustang Bio, Inc.
APTOAptose Biosciences Inc.
ATHAAthira Pharma, Inc.
RVPHReviva Pharmaceuticals Holdings, Inc.
ACADACADIA Pharmaceuticals Inc.
CABACabaletta Bio, Inc.
KODKodiak Sciences Inc.
ACHLAchilles Therapeutics plc
PIRSPieris Pharmaceuticals, Inc.
CGTXCognition Therapeutics, Inc.
ATXIAvenue Therapeutics, Inc.
LUMOLumos Pharma, Inc.

FBIO Ownership FAQ


Fortress Biotech is owned by institutional shareholders (18.02%), insiders (22.55%), and public (59.43%). The largest institutional shareholder of Fortress Biotech is B. RILEY WEALTH ADVISORS, INC. (0.96% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.27% of total shares).

Fortress Biotech's major institutional shareholders are B. RILEY WEALTH ADVISORS, INC.. The top five shareholders own together 0.96% of the company's share outstanding.

As of Sep 2023, there are 46 institutional shareholders of Fortress Biotech.

B. RILEY WEALTH ADVISORS, INC owns 144.7K shares of Fortress Biotech, representing 0.96% of the company's total shares outstanding, valued at $42.01K (as of Mar 2024).